An update on the relevance of vaccine research for the treatment of metastatic melanoma
Signal transduction inhibitors and anticheckpoint antibodies have significantly improved survival for metastatic melanoma patients, but most still die within 5 years. Vaccine approaches to induce immunity to well-characterized melanoma-associated antigens, or to antigens expressed on allogeneic tumo...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2017-12-01
|
| Col·lecció: | Melanoma Management |
| Matèries: | |
| Accés en línia: | https://www.futuremedicine.com/doi/10.2217/mmt-2017-0021 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|